SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Atb Cap Markets decreased their Q2 2025 earnings per share (EPS) estimates for shares of SNC-Lavalin Group in a research note issued to investors on Thursday, May 15th. Atb Cap Markets analyst C. Murray now forecasts that the company will post earnings per share of $0.68 for the quarter, down from their previous forecast of $0.70.
Separately, Stifel Canada raised shares of SNC-Lavalin Group to a “strong-buy” rating in a research note on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
About SNC-Lavalin Group
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Recommended Stories
- Five stocks we like better than SNC-Lavalin Group
- Short Selling – The Pros and Cons
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- How to Buy Gold Stock and Invest in Gold
- What Ray Dalio’s Latest Moves Tell Investors
- The Basics of Support and Resistance
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
